Research Article
Pharmacokinetics of Acetylsalicylic Acid and Salicylic Acid After Intravenous Administration in Man

https://doi.org/10.1002/jps.2600570807Get rights and content

Abstract

The pharmacokinetics of acetylsalicylic acid (ASA, 650 mg.) and salicylic acid (SA, 500 mg.) were studied following intravenous administration in males. The resultant plasma concentration-time curves were described by bi-exponential equations. The half-life of the first exponent was 2–5 min. for both compounds while that of the second exponent was 13–19 min. and 3.5–4.5 hr. for ASA and SA, respectively. Over the dose range 0.3–1.2 g. ASA, the area under the ASA plasma concentration-time curve was proportional to the dose administered. Also SA was shown to be the exclusive metabolite of ASA. Analysis of the present results, over the dose range and duration of study, showed that the data could best be fitted by conceiving the body to act as a two-compartmental open system with respect to these drugs. The significance of these findings on measurement of the rate constants of metabolism, volume of distribution, and other pharmacokinetic parameters are discussed.

References (23)

  • A.M. Morgan et al.

    J. Pharm. Sci.

    (1965)
  • V.F. Cotty et al.

    J. Pharm. Sci.

    (1965)
  • V.F. Cotty et al.

    J. Pharm. Sci.

    (1966)
  • G. Levy

    J. Pharm. Sci.

    (1965)
  • M. Rowland et al.

    J. Pharm. Sci.

    (1967)
  • J.V. Swintosky

    J. Am. Pharm. Assoc., Sci. Ed.

    (1956)
  • G. Levy

    J. Pharm. Sci.

    (1965)
  • M. Gross et al.

    The Salicylate

    (1948)
  • M.J.H. Smith et al.

    The Salicylate

    (1966)
  • A.St.J. Dixon et al.

    Salicylate

    (1963)
  • W. Lange et al.

    J. Pharm. Sci.

    (1966)
  • Cited by (158)

    • Old wine in new bottles: Drug repurposing in oncology

      2020, European Journal of Pharmacology
      Citation Excerpt :

      According to the results from the studies performed in healthy volunteers, the peak plasma concentration after administration of soluble aspirin (600 mg per day) was higher than that of other orally administered formulations (13.82 μg/ml versus 5.51 μg/ml with 650 mg plain aspirin per day orally), as well as the half-life was twice shorter (16 min versus 32 min, respectively) (Muir et al., 1997). However, such a study did not include intravenous aspirin, which has been shown to have the half-time of 2.8 min and 15 min in the initial distribution and the elimination phase, respectively (Rowland and Rielgelma, 1968); it has been indicated that intravenous aspirin is rapidly converted to salicylic acid by hydrolysis and presystemic COX-2 acetylation (Nagelschmitz et al., 2014), which may contribute to its antiplatelet and other pharmacologic effects (Giménez-Bastida et al., 2019). Anyway, aspirin at doses of 1 g per day (or higher) administered intravenously or orally is not recommended as atherothrombotic prophylaxis (FitzGerald et al., 1983).

    • A kinetic-based safety assessment of consumer exposure to salicylic acid from cosmetic products demonstrates no evidence of a health risk from developmental toxicity

      2018, Regulatory Toxicology and Pharmacology
      Citation Excerpt :

      Three studies were identified in the literature where ASA was administered IV (Bochner et al., 1988; Nagelschmitz et al., 2014; Rowland and Riegelman, 1968). The Rowland and Riegelman, 1968 study was not taken into account because the sensitivity of the method used for ASA detection was considered low and not sufficiently accurate (Bochner et al., 1988). The Nagelschmitz et al. (2014) study tested a larger number of subjects (N = 21) compared to the Bochner et al. (1988) (N = 6) study, but used higher doses of ASA (250 mg and 500 mg) compared to the low dose of 50 mg ASA administered in the Bochner et al. (1988) study.

    • Exploring the efficacy of immersion analgesics in zebrafish using an integrative approach

      2017, Applied Animal Behaviour Science
      Citation Excerpt :

      However, the non-detection of ASA from whole body homogenate does not necessarily mean that no uptake had occurred. In human trials the drug has been shown to be hydrolyze quickly after intravenous injection, with a half-life of less than 3 min (Rowland and Riegelman, 1968). In the present study ASA (rather than salicylic acid resulting from hydrolysis) was used as reference compound for mass spectrometry and there may simply not have been sufficient pre-hydrolysis ASA in the body homogenate.

    • Salicylates

      2007, Haddad and Winchester's Clinical Management of Poisoning and Drug Overdose, Fourth Edition
    View all citing articles on Scopus

    Supported in part by funds from the University of California, Academic Senate Research Committee, and Sterling-Winthrop Laboratories, Rensselaer, N. Y.

    View full text